EpiPGX project video – review and forecast after 4 years of ambitious epilepsy research

Epilepsy pharmacogenomics: delivering biomarkers for clinical use.

What is the innovation capacity of EpiPGX‬ project? And what makes this EU- funded ‪epilepsy‬ project so valuable?
After four years of scientific research, the consortium presents its latest findings on epilepsy ‪‎pharmacogenomics‬. The project gives hope to about 50 million people who suffer from epilepsy worldwide. It’s aim is to individualise and optimise epilepsy treatment with the best outcome for the patients.

https://www.youtube.com/watch?v=CwGtrz4XdOc

Mots‑clés

• epilepsy
• health
• pharmacogenomics
• research
• biomarkers
• biomarkers for clinical use

Pays

Belgium, Germany, Finland, Ireland, Iceland, Italy, Luxembourg, Netherlands, United Kingdom